Irinotecan Hydrochloride 67184-0511
Product NDC
67184-0511- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 3, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA203380
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 20 mg/mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (67184-0511-1) / 2 mL in 1 VIAL, SINGLE-USE